Key facts
- The Trump administration is ending a Medicare Part D subsidy program that has offset premiums for the past two years.
- The program's conclusion in 2027 could lead to higher monthly costs for millions of older adults on Medicare.
- The Centers for Medicare & Medicaid Services (CMS) announced the program's termination.
- Democrats argue this move will increase prescription drug costs for 25 million seniors.
- CMS Administrator Dr. Mehmet Oz stated the program's termination would save billions in taxpayer dollars and that most beneficiaries would see less than a $10 monthly increase.
The Trump administration has announced it will conclude a temporary subsidy program that has helped offset Medicare Part D prescription drug premiums since 2024. This decision, set to take effect in 2027, could lead to increased monthly costs for millions of older adults. The program was initially implemented by the Biden administration in response to the effects of the 2022 Inflation Reduction Act.
Federal officials maintain that the financial impact on Medicare beneficiaries will be minimal, with CMS Administrator Dr. Mehmet Oz stating that most beneficiaries would see less than a $10 monthly increase and that the move would prevent billions in taxpayer dollars from going to insurance companies. He also noted that beneficiaries still have access to low-cost plans and that the administration continues to work on lowering prescription drug prices.
However, Democrats have strongly criticized the decision. Senate Minority Leader Chuck Schumer called the move "heartless, cruel, and completely by choice," framing it as part of a pattern of attacks on healthcare affordability. The timing of the announcement, just before a high-stakes midterm election year where cost of living is a major concern for voters, opens the administration to potential political backlash, particularly from older adults on fixed incomes.